A longitudinal VBM study monitoring treatment with erythropoietin in patients with Friedreich ataxia (Q34285714)

1 August 2017

A longitudinal VBM study monitoring treatment with erythropoietin in patients with Friedreich ataxia (English)

1 reference

1 August 2017

1 reference

1 reference

Wolfram Santner

1

1 reference

1 August 2017

Michael Schocke

2

1 reference

1 August 2017

Sylvia Boesch

3

1 reference

1 August 2017

Wolfgang Nachbauer

4

1 reference

1 August 2017

Karl Egger

5

1 reference

1 August 2017

12 May 2014

1 reference

Acta radiologica short reports

1 August 2017

1 reference

1 August 2017

3

1 reference

1 August 2017

4

1 reference

1 August 2017

2047981614531573

1 reference

White matter changes in patients with friedreich ataxia after treatment with erythropoietin

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4184378

Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4184378

Therapeutic strategy of erythropoietin in neurological disorders

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4184378

TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4184378

The role of erythropoietin in neuroprotection: therapeutic perspectives

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4184378

Systemically delivered Erythropoietin transiently enhances adult hippocampal neurogenesis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4184378

Clinical features and molecular genetics of autosomal recessive cerebellar ataxias

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4184378

mTOR pathway as a target in tissue hypertrophy.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4184378

Scale for the assessment and rating of ataxia: development of a new clinical scale

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4184378

Recombinant human erythropoietin: effects on frataxin expression in vitro

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4184378

Beneficial effect of erythropoietin on experimental allergic encephalomyelitis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4184378

An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4184378

The cardiovascular effects of erythropoietin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4184378

Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4184378

Erythropoietin--a novel concept for neuroprotection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4184378

A voxel-based morphometric study of ageing in 465 normal adult human brains

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4184378

Voxel-based morphometry–the methods

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4184378

Brain structural damage in Friedreich's ataxia.

6 July 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047981614531573

Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: a clinical pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047981614531573

Image registration using a symmetric prior--in three dimensions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047981614531573

SARA--a new clinical scale for the assessment and rating of ataxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047981614531573

Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047981614531573

Uncoupling of neurodegeneration and gliosis in a murine model of juvenile cortical lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047981614531573

Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047981614531573

Cerebral glucose hypermetabolism in Friedreich's ataxia detected with positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047981614531573

Effects of the use of multiple scanners and of scanner upgrade in longitudinal voxel-based morphometry studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047981614531573

Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047981614531573

Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25298866

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25298866

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25298866

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1177/2047981614531573

1 reference

1 August 2017

1 reference

1 August 2017

1 reference